Work

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer

Year: 1990

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00177255

Authors: David S. Ettinger, Dianne M. Finkelstein, Martin D. Abeloff, Yuang-Chi Chang, Thomas J. Smith, Martin M. Oken, John C. Ruckdeschel

Institutions: Johns Hopkins Hospital, Harvard University, Dana-Farber Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, University of Rochester Medicine, University of Rochester, Tufts Medical Center, University of Minnesota, Albany Medical College

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1257575315, G1422427855, Eastern Cooperative Oncology Group, Southwest Oncology Group, G5765316850, ECOG Statistical Office

OpenAlex ID: W2002872847

FWCI: 0.172

Cites: 4

Cited by: 5

Related to: 10